Finishing treatment for endometrial (uterine) cancer is a significant milestone, but staying vigilant afterward matters just as much. Cancer recurrence is a real concern for many survivors, with most recurrences happening within the first three years after treatment ends. That’s why a structured monitoring plan isn’t optional. It’s a core part of your care. Monitoring […]

Endometrial (uterine) cancer care is evolving. Beyond stage and grade, doctors are using molecular information to understand how a tumor behaves and how best to treat it. As treatment becomes more personalized, researchers are looking for better ways to monitor disease. One promising area of research is circulating tumor DNA (ctDNA). ctDNA consists of tiny […]

When facing uterine (endometrial) cancer, understanding your treatment options is key. Surgery, chemotherapy, radiation, or hormone therapy may be recommended depending on your stage. Clinical trials can provide additional opportunities for treatments tailored to your specific tumor profile. They can help patients access promising therapies while contributing to research that improves care for others. In […]